Clinical trials for both the Pfizer-BioNTech BNT162b2 and Moderna messenger RNA (mRNA)-1273 COVID-19 vaccines demonstrated ability to prevent infection and severe disease, leading to emergency use authorization by the U.S. Food and Drug Administration in December 2020.1,2 The American College of Obstetrics and Gynecology and The Society for Maternal Fetal Medicine have recommended that these […]